Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial
暂无分享,去创建一个
H. Döhner | H. Dombret | B. Skikne | U. Martens | F. Ravandi | A. Wei | J. Liesveld | J. Braverman | G. Roboz | J. Jang | D. Selleslag | J. Mayer | Shien Guo | C. Pocock | T. Bernal | Qian Dong | P. Yu | C. Beach | I. La Torre | M. Wang | S. A. Nehme | L. Shi | Ling Shi